Corporate News     13-Aug-20
Alembic Pharmaceuticals' JV with Aleor receives USFDA approval for Tavaborole Topical Solution
Alembic Pharmaceuticals announced that its joint venture Aleor Dermaceuticals (Aleor) has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Tavaborole Topical Solution, 5%.The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Kerydin Topical Solution, 5%, of Anacor Pharmaceuticals, Inc. (Anacor). Tavaborole topical solution, 5% is an oxaborole antifungal indicated for the treatment of onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes.

Tavaborole Topical Solution, 5% has an estimated market size of US$ 82 million for twelve months ending June 2020 according to IQVIA. Alembic is currently in litigation with Anacor in District Court of Delaware and launch of the product will depend on litigation outcome.

Alembic has a cumulative total of 128 ANDA approvals (112 final approvals and 16 tentative approvals) from USFDA.

Previous News
  Alembic Pharmaceuticals receives USFDA tentative approval for Ivosidenib Tablets
 ( Corporate News - 04-Jul-24   16:11 )
  Benchmarks trade with decent gains; Auto shares rally for 2nd day
 ( Market Commentary - Mid-Session 04-Jul-24   14:37 )
  Alembic Pharma rises after receiving USFDA nod for cancer drug
 ( Hot Pursuit - 04-Jul-24   13:00 )
  Alembic Pharmaceuticals receives USFDA approval (final & tentative) for 11 products
 ( Corporate News - 03-Jul-24   15:42 )
  Market near day's high; metal shares rally for 3rd day
 ( Market Commentary - Mid-Session 01-Jul-24   12:34 )
  Alembic Pharma spurts on USFDA nod for leukemia drug
 ( Hot Pursuit - 01-Jul-24   11:06 )
  Alembic Pharmaceuticals receives USFDA tentative approval for Bosutinib tablets
 ( Corporate News - 01-Jul-24   10:44 )
  Alembic Pharmaceuticals receives USFDA approval for Doxycycline Capsules
 ( Corporate News - 28-Jun-24   13:38 )
  Alembic Pharma gets USFDA nod for Doxycycline Capsules
 ( Hot Pursuit - 28-Jun-24   12:20 )
  Alembic Pharmaceuticals to hold AGM
 ( Corporate News - 22-Jun-24   17:42 )
  Alembic Pharmaceuticals receives USFDA approval for Dabigatran Etexilate Capsules
 ( Corporate News - 18-Jun-24   18:52 )
Other Stories
  Tinna Trade raises Rs 49 cr to fund its growth plans
  06-Jul-24   11:10
  Integra Essentia announces merger with G G Engineering
  06-Jul-24   11:05
  Ugro Capital to raise Rs 75 cr via NCD issuance
  06-Jul-24   10:58
  Board of D.P. Abhushan approves preferential allotment of shares and warrants
  06-Jul-24   10:50
  Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
  06-Jul-24   10:49
  High Energy Batteries (India) to discuss results
  06-Jul-24   10:29
  Havells India schedules board meeting
  06-Jul-24   10:29
  Axis Bank announces board meeting date
  06-Jul-24   10:29
  Mastek to conduct board meeting
  06-Jul-24   10:29
  Oriental Hotels to conduct board meeting
  06-Jul-24   10:29
Back Top